The Usefulness of Defining Rapid Virological Response by a Very Sensitive Assay (TMA) during Treatment of HCV Genotype 2/3 Infection

• Olav Dalgard ,

  * E-mail: odalgard@medisin.uio.no

  Affiliations Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Michelle Martinot-Peignoux,

  Affiliation Institut National de la Santé et de la Recherche Médicale, U-773, Centre de Recherche Biomédicale Bichat-Beaujon CRB3, Université Paris VII, Paris, France

  ⨯
• Hans Verbaan,

  Affiliation Medical Department, Malmø University Hopsital, Malmø, Sweden

  ⨯
• Kristian Bjøro,

  Affiliations Clinic for specialized Medicine and Surgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Helmer Ring-Larsen,

  Affiliation Department of Pharmacology and Pharmacotherapy, University of Copenhagen, Copenhagen, Denmark

  ⨯
• Patrick Marcellin

  Affiliation Service d'Hépatologie, Hŏpital Beaujon, Clichy, France

  ⨯